DIRS.INFO The most relevant business & tech news

☆ Medical device stocks rise in relief after Wegovy heart benefits data
▼ + stars: | 2023-11-13 | by ( ) www.reuters.com time to read: +2 min

A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. To be sure, the full results presented on Saturday at a major medical meeting gave analysts even more confidence in the heart protective benefits of the hugely popular drug. That lifted shares of Penumbra (PEN.N), which makes devices used in surgeries for stroke patients, 13% in morning trading. Its shares have tumbled about 28% as of last close since Novo in August said Wegovy had also shown a clear cardiovascular benefit. "The full detailed results ... do not shift our outlook that MedTech device stocks appear broadly oversold," said Leerink analyst Mike Kratky.

Persons: Victoria Klesty, Wegovy, Baird, Jeff Johnson, Eli Lilly's, Mike Kratky, Leroy Leo, Medha Singh, Sriraj Organizations: REUTERS, Novo, Devices, Abbott Laboratories, Thomson Locations: Oslo, Norway, Victoria, MedTech, Penumbra, Novo, Friday's, Bengaluru

HEAVY FIGHTING NEAR SHIFA HOSPITALPolitical Cartoons View All 1240 ImagesIn Gaza City, residents reported heavy airstrikes and shelling overnight, including in the area around Shifa Hospital. Israel, without providing evidence, has accused Hamas of concealing a command post inside and under the hospital compound, allegations denied by Hamas and hospital staff. “We spent the night in panic waiting for their arrival,” said Ahmed al-Boursh, a resident taking shelter in the hospital. Israel’s military confirmed clashes outside the hospital, but Rear Adm. Daniel Hagari, a spokesman, denied Shifa was under siege. Netanyahu said Gaza would be demilitarized and that Israel would retain security control, with the ability to enter Gaza freely to hunt down militants.

Persons: KHAN YOUNIS, Benjamin Netanyahu, Israel, “, ”, Ahmed al, Mohammed Abu Selmia, Daniel Hagari, Shifa, Robert Mardini, Crescent, NETANYAHU, Netanyahu, Antony Blinken, Ebrahim Raisi, ___ Magdy Organizations: Israel, Hamas, Health Ministry, World Health Organization, International Committee, Red Cross, Palestinian, Palestinian Authority, West Bank Locations: Gaza, Gaza City, Israel, United States, Saudi Arabia, London, SHIFA, Shifa, “, al, Quds, Hamas, U.S, Iran, Egypt, Rafah, Tel Aviv, Caesarea, Netanyahu's, Lebanon, Cairo, ___, israel

☆ I'm a cruise-ship doctor. My schedule is intense but it's worth it to see the world — and I get to bring my wife and son along.
▼ + stars: | 2023-11-11 | by ( Kitti Palmai | ) www.businessinsider.com time to read: +7 min

AdvertisementAdvertisementThis as-told-to essay is based on a transcribed conversation with Dr. Gergely Tóth, a cruise-ship doctor. Having more medical experience under my belt, I emailed three cruise companies enquiring about how to become a cruise doctor. Cruises have full medical teams and facilitiesDepending on the size of the cruise, the medical team consists of five to nine people. A cruise doctor's schedule is intenseDoctors usually work for four months and have two months off. On large cruises, it means a daily 15 hours of work and nine hours of being on-call, then getting 24 hours off.

Persons: Gergely Tóth, Tóth, —, Gergely, who'd, I've, I'd, I'm, we're Organizations: Service, Nuffield Health Cheltenham Hospital, Royal Caribbean International, Cruises Locations: Hungary, England, British, London, Miami, San Francisco

☆ These losing stocks could surge as the year winds down, Bank of America says
▼ + stars: | 2023-11-10 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +3 min

One investor's portfolio loser could be another's winning stock as 2023 draws to a close, according to Bank of America. Buy rated and cheap Bank of America screened for buy-rated stocks that fell at least 10% in 2023 through the end of October that were also overweight by long-only funds as of September. However, Bank of America still rates both names as buys – and others on Wall Street spot potential. Retailer Target is another name that made the cut, garnering a buy rating from Bank of America. Other stocks in Bank of America's list include agriculture play Mosaic , life insurer MetLife , defense giant Northrop Grumman , as well as gas and electric utility CenterPoint Energy .

Persons: Savita Subramanian, Dexcom, Insulet, –, Piper Sandler's Matt O'Brien, — CNBC's Michael Bloom Organizations: Bank of America, Internal Revenue, Bank of, Target, MetLife, Northrop, CenterPoint Energy Locations: Bank of America, Bank

☆ Czech firm Bene Meat gets EU approval for lab-grown meat for pet food
▼ + stars: | 2023-11-08 | by ( Jan Lopatka | ) www.reuters.com time to read: +3 min

[1/4] An employee works at a laboratory of Bene Meat Technologies company, which is planning to scale up production of lab-grown meat for use in pet food, in Prague, Czech Republic, November 7, 2023. Bene Meat has turned its focus to the pet food sector to deliver a product that can be marketed to global pet food makers as a raw material for inclusion in their final products. He said Bene Meat's costs would allow final products to sell around the price level of premium and super-premium pet food products on the market. The company is in talks with pet food makers on supplies, but also aims to work with them to potentially set up production lines at their current facilities. It also plans to develop its own brand of final pet food products.

Persons: David W Cerny, Meat, Roman Kriz, Kriz, Bene, Jan Lopatka, Sharon Singleton Organizations: Bene Meat Technologies, REUTERS, Bene, Technologies, European Union, Reuters, Thomson Locations: Prague, Czech Republic, PRAGUE, Czech, United States, Singapore

☆ A value fund manager who's beaten 99% of his peers in the last three years explains how he avoids bad investments — and makes the case for 3 stocks he loves heading into 2024
▼ + stars: | 2023-11-05 | by ( James Faris | ) www.businessinsider.com time to read: +7 min

The 31-year market veteran has achieved enviable results since the start of 2005 while running the BNY Mellon Dynamic Value Fund (DAGVX) alongside co-manager Brian Ferguson. How to invest — and common mistakes to avoidLike all value fund managers, Bailer refuses to overpay for stocks — regardless of how enticing their businesses look. "It's a philosophy that's based on looking for stocks with great valuations, but not stopping with great valuations," Bailer said. Companies in the BNY Mellon Dynamic Value Fund must have both quality fundamentals and improving business momentum, Bailer said. The six largest stocks in the BNY Mellon Dynamic Value Fund were in one of two sectors, as of September 30: financials and healthcare.

Persons: John Bailer, Brian Ferguson, it's, Bailer, we've, headwinds, they've, he's, Warren Buffett, Berkshire Hathaway, Buffett, Charlie Munger Organizations: Value Fund, Companies, Value, Firms, Berkshire, JPMorgan Locations: Berkshire

☆ Indian economy regains its swagger as China stumbles
▼ + stars: | 2023-11-03 | by ( Diksha Madhok | ) edition.cnn.com time to read: +9 min

New Delhi CNN —India’s economy is like an elephant. India’s economy is currently worth nearly $3.5 trillion, making it the world’s fifth largest. “India’s economy is comfortably placed to grow at an annual rate of at least 6% in the coming few years,” Barclays said. But even as India’s heft is increasing, it is far from recreating the economic miracle China unleashed decades ago. It will, no doubt — though it won’t be enough to shield the world economy should China’s economy stumble badly,” they added.

Persons: Narendra Modi, ”, Eswar Prasad, Modi, Prasad, Ludovic Marin, Mukesh Ambani’s, Gautam Adani’s, Willy Shih, Frederic Neumann, Justin Feng Organizations: New, New Delhi CNN, Economic, Cornell University, International Monetary Fund, China, Barclays, IMF, ” Barclays, Hindustan Times, Modi, bonanza, Unified, Bharat, Getty, Bank, Mukesh Ambani’s Reliance Industries, Apple, Harvard Business School, HSBC Locations: New Delhi, India, Switzerland, Davos, ”, ’, China, ” New Delhi, Sewri, Mumbai Bhushan, AFP, Beijing, Washington

☆ GE HealthCare beats quarterly profit estimates on imaging device demand
▼ + stars: | 2023-10-31 | by ( ) www.reuters.com time to read: +2 min

A logo is displayed on a GE digital anesthesia carestation as U.S. Vice President Mike Pence (not pictured) visits a GE Healthcare manufacturing facility during the global coronavirus disease (COVID-19) outbreak in Madison, Wisconsin, U.S. April 21, 2020. Larger peer Abbott Laboratories (ABT.N) also topped its quarterly profit estimates, aided by a recovery in sales of its medical devices such as heart valves and pacemakers. In the previous quarter, GE HealthCare had said that Alzheimer's-related testing would help drive demand for its imaging equipment at hospitals and medical centers next year. $2.64 billion of the sales came from imaging devices, in line with estimates. On an adjusted basis, GE HealthCare earned 99 cents per share, above LSEG estimates of 90 cents.

Persons: Mike Pence, Daniel Acker, Christy Santhosh, Maju Samuel Organizations: GE, GE Healthcare, REUTERS, GE HealthCare Technologies Inc, Abbott Laboratories, GE HealthCare, Thomson Locations: Madison , Wisconsin, U.S, COVID, United States, Bengaluru

☆ A top-9% fund manager shares how he built an 'anti-fragility' portfolio that outperforms in bull and bear markets — and shares 8 of his favorite investments to make now
▼ + stars: | 2023-10-29 | by ( James Faris | ) www.businessinsider.com time to read: +7 min

His foreign-focused, large-cap growth fund is in the top 9% of its category in 2023 with a 4.8% gain compared to a 0.5% loss for its index, according to Morningstar. "And so we don't recalibrate the portfolio much year in, year out or rebalance it for different macro outlooks." Target top-of-the-line stocks, but pay a fair priceUnlike many other managers, Erickson only allows a few dozen stocks in his fund. 8 top investments to make nowMany US-based investors avoid international stocks entirely since the prevailing narrative is that the group is risky, given its heightened exposure to geopolitical conflict. International stocks in four sectors look especially promising right now, Erickson said: consumer discretionary, consumer staples, healthcare, and information technology.

Persons: Elias Erickson, he's, Morningstar, Erickson, We're, It's, there's Organizations: Companies, SAP, Mastercard Locations: New York

Such forecasts have prompted a sell-off in a wide range of companies from makers of bariatric surgery devices to companies whose products address the health issues created by excess weight, from diabetes to sleep apnea. "The market is in a shoot-first, ask-questions-later mood when it comes to weight-loss drugs," said Nicholas Anderson, manager of the Thornburg International Growth Fund, which holds shares of Novo Nordisk. By contrast, the iShares U.S. Medical Devices exchange-traded fund has lost more than 22% in the last three months. Injectable weight-loss drugs, known as GLP-1 receptor agonists, are considered highly effective but are also expensive, costing more than $1,300 per month. "Overall, we'll see an increased interest in bariatric surgery, but that will get delayed in the short term."

Persons: Doctor Thomas Horbach, Wegovy, Nicholas Anderson, Eli Lilly, Kenneth Stein, Margaret Kaczor Andrew, William Blair, Michael Farrell, Jeff Jonas, Johnson, Myriam Curet, Ann Hynes, Hynes, David Gaffen, Manas, Michael Erman, Caroline Humer, Sonali Paul Organizations: Novo Nordisk, Healthcare, Growth Fund, Medical Devices, Boston, Gabelli Funds, Johnson, Reuters, Mizuho Securities, Manas Mishra, Thomson Locations: Germany, Munich, Danish, U.S, Boston, GLP, New York, Bengaluru

☆ Stocks making the biggest moves after hours: Intel, Amazon, Chipotle, Enphase Energy and more
▼ + stars: | 2023-10-26 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Amazon issued fourth-quarter sales guidance ranging between $160 billion to $167 billion, while analysts polled by LSEG called for revenue of $166.6 billion. Intel earned 41 cents per share, adjusted, on $14.16 billion in revenue, while analysts polled by LSEG had expected 22 cents per share in earnings and revenue at $13.53 billion. Earnings per share came in at $4.45 versus the $3.24 per share expected by analysts polled by FactSet. Analysts polled by FactSet expected earnings of 34 cents per share and revenue at $939.6 million. Analysts polled by LSEG called for $22.64 in earnings per share and $4.015 billion in revenue.

Persons: LSEG, Ford, Dexcom, FactSet, —, Darla Mercado Organizations: Amazon, Intel, Ford —, Ford, LSEG, FactSet, Enphase Energy, Revenue

☆ West’s latest China corporate risk: medical graft
▼ + stars: | 2023-10-23 | by ( Karen Kwok | ) www.reuters.com time to read: +4 min

An employee wearing a face mask is seen at a workshop of computed tomography (CT) scanners of medical device firm Siemens Healthineers in Shanghai, China, February 24, 2020. REUTERS/Aly Song Acquire Licensing RightsLONDON, Oct 23 (Reuters Breakingviews) - China corporate risk has spread to Western medical device companies. According to BMI analysts, about two-thirds of Chinese medical devices used by local hospitals and clinics are imported from Western groups. That implies a direct hit to the order and revenue growth for medical device firms. Domestic brands, which have historically lagged in the advanced end of the medical device market, took the whole of last decade just to hike their share from around 20% to 30%, Deloitte says.

Persons: Aly, Philips, George Hay, Oliver Taslic Organizations: Siemens, REUTERS, Reuters, Volkswagen, Philips, GE Healthcare, BMI, National Health Commission, Siemens Healthineers, Reuters Graphics Reuters, Deloitte, GE, Healthineers, Thomson Locations: Shanghai, China, People’s Republic, Beijing, United States

☆ HealthCaters enables people to screen themselves at home for preventable diseases. Check out the 14-slide pitch deck it used to raise $1.2 million.
▼ + stars: | 2023-10-19 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +2 min

A startup that offers personalized health screenings for individuals and employees has just raised $1.2 million in fresh funds. Berlin-based HealthCaters, which was founded three years ago, has developed a home-testing kit so that users can screen themselves for preventable diseases. The startup's app, which is also powered by AI, then suggests personalized health guidelines based on the results of these screenings. Based on these results, medical coaches at the startup create an individual health plan for patients. With the fresh funding, HealthCaters will double down on its business-to-business offerings, and eye a launch in the UK market.

Persons: Tatyana Eliseeva, aren't, Daniel Ek, Dr, Lilia Kruse, HealthCaters Organizations: IBM, DvH Ventures Locations: Berlin, HealthCaters, Germany, Europe

REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsOct 18 (Reuters) - Abbott Laboratories (ABT.N) said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs, adding the treatments could end up boosting sales of the medical device maker. The company's shares have dropped 16% this year, mainly on concerns that new GLP-1 diabetes drugs such as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro could eat into the sales of its continuous glucose monitoring (CGM) devices. Hurdles in health insurance reimbursement and pricing could, however, keep market growth for GLP-1 drugs limited to a small number of patients in the near term, Abbott CEO Robert Ford said on Wednesday. Third-quarter sales of FreeStyle Libre, Abbott's CGM device used by diabetes patients, jumped 30.5% to $1.4 billion, lifting Abbott's shares 3% in morning trade. The numbers helped Abbott's medical device sales that stood at $4.25 billion, beating analysts' estimates of $4.16 billion, according to LSEG data.

Persons: Brendan McDermid, Nordisk's Ozempic, Eli Lilly's, Abbott, Robert Ford, Ford, Vijay Kumar, Pratik Jain, Leroy Leo, Anil D'Silva, Shounak Dasgupta, Shinjini Organizations: Abbott, New York Stock Exchange, REUTERS, Abbott Laboratories, Nordisk's, Thomson Locations: New York City, U.S, GLP, Bengaluru

☆ Stocks making the biggest moves midday: United Airlines, Nvidia, Morgan Stanley and more
▼ + stars: | 2023-10-18 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

Late Tuesday, the company posted third-quarter results that fell short of Wall Street's expectations on the top and bottom lines. The company posted third-quarter adjusted earnings of $1.55 per share on adjusted revenue of $1.14 billion. Abbott posted earnings of $1.14 per share, excluding items, beating analysts' estimates by 4 cents a share, according to FactSet. It posted revenue of $2.69 billion, which was not immediately comparable to consensus estimates. It posted revenue of $771.0 million, lower than the consensus estimate of $784.3 million, according to FactSet.

Persons: Morgan Stanley, . Hunt, Gamble — Procter, LSEG, Abbott, Michael Happe, —, Yun Li, Sarah Min, Tanaya, Hakyung Kim, Pia Singh Organizations: United Airlines —, United Airlines, Nvidia, U.S, Citi, Devices, Marvell Technology, Hunt Transport Services, LSEG, Interactive, Procter, Gamble, Abbott, Financial, Citizens Financial, State, FactSet, Winnebago Industries, Winnebago, Bancorp, U.S . Bancorp, Bank of America Locations: Tel Aviv, Israel, China, LSEG, Albemarle —

☆ Abbott profit beats on strong sales of medical devices, diagnostics
▼ + stars: | 2023-10-18 | by ( ) www.reuters.com time to read: +1 min

Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsOct 18 (Reuters) - Abbott Laboratories (ABT.N) on Wednesday tightened its profit forecast for the year after beating estimates for third-quarter earnings on strong demand for its medical devices and diagnostics products. The company is seeing a recovery in sales of its medical devices such as heart valve devices and pacemakers as more older people opt for surgeries that were put off due to the pandemic. Abbott posted a near 17% rise in quarterly sales of its medical devices to $4.25 billion, beating analysts' estimates of $4.16 billion. Excluding items, Abbott earned $1.14 per share, above analysts' estimates of $1.10 per share, according to LSEG data.

Persons: Brendan McDermid, Abbott, Nordisk's Ozempic, Eli Lilly's, Mounjaro, Pratik Jain, Leroy Leo, Anil D'Silva Organizations: Abbott, New York Stock Exchange, REUTERS, Abbott Laboratories, Libre, Nordisk's, Thomson Locations: New York City, U.S, Bengaluru

☆ 'We don't see' weight-loss drugs impacting medical devices' sales, says Abbott CEO Robert Ford
▼ + stars: | 2023-10-18 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email'We don't see' weight-loss drugs impacting medical devices' sales, says Abbott CEO Robert FordRobert Ford, Abbott chairman and CEO, joins 'Closing Bell Overtime' to talk Q3 earnings, the impact of weight loss drugs on their product and more.

Persons: Robert Ford Robert Ford, Abbott

The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. J&J raised its annual profit forecast, helped by strong sales from its pharmaceutical business, and shares of the U.S. healthcare conglomerate were off about 1%. Excluding its consumer health unit, J&J now expects 2023 adjusted profit of $10.07 to $10.13 per share, up from its previous view of $10.00 to $10.10. Sales at J&J's medical device unit came in at $7.46 billion, shy of Wall Street estimates of $7.58 billion. J&J finalized the biggest shake-up in its 137-year history in August with the spinoff, but retained a 9.5% stake in its iconic consumer health business.

Persons: Johnson, Yves Herman, J, Vamil Divan, Joseph Wolk, Ozempic, Wolk, Bhanvi Satija, Sriparna Roy, Patrick Wingrove, Shounak Dasgupta, Bill Berkrot Organizations: Johnson, REUTERS, Guggenheim Partners, Vamil, Reuters Graphics, J, Thomson, &' $, & $, & $ Locations: Brussels, Diegem, Belgium, Bengaluru, New York

The logo of Johnson & Johnson is seen on a Brussels' office of the company in Diegem, Belgium September 21, 2023. Investors are focused on how J&J, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025. Johnson & Johnson recorded a $21-billion gain in the third quarter from the spin-off of its consumer health unit. Stelara, J&J's top-selling anti-inflammatory drug, brought in sales of $2.86 billion in the quarter, above LSEG estimates of $2.61 billion. Excluding its consumer health unit, J&J now expects 2023 adjusted profit of $10.07 to $10.13 per share, compared with its previous outlook of $10.00 to $10.10 per share.

Persons: Johnson, Yves Herman, MedTech, Cantor Fitzgerald, Louise Chen, Stelara, Joseph Wolk, Wolk, J, Bhanvi Satija, Sriparna Roy, Patrick Wingrove, Shounak Dasgupta Organizations: Johnson, REUTERS, Innovative Medicine, Reuters, Thomson, & $, & $ Locations: Brussels, Diegem, Belgium, Stelara, U.S, United States, Bengaluru, New York

☆ Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge
▼ + stars: | 2023-10-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street's expectations, and lifted its full-year guidance as sales in the company's pharmaceutical and medical devices businesses surged. Upon that split, J&J lowered its full-year sales and profit guidance. J&J also expects adjusted earnings per share of $10.07 to $10.13, up from a previous forecast of $10.00 to $10.10. The pharmaceutical giant reported net income of $4.31 billion, or $1.69 per share. That was flat compared with net income of $4.31 billion, or $1.62 per share, for the same period a year ago.

Persons: Johnson, J, Joseph Wolk Organizations: LSEG

The funds were moved to Qatari accounts as part of a broad deal to secure the release of five Americans whom the US deemed had been wrongfully detained in Iran. There were bipartisan calls to freeze the funds in the wake of the deadly Hamas attacks in Israel this weekend. Still, the “quiet understanding” not to move the money right now appears to be largely symbolic, given the strict restrictions that were already tied to the funds. Blinken did not confirm that “a quiet understanding” had been reached but made clear the US is able to freeze the funds. The process for Iran to be able to spend the funds was expected to take months, if not years.

Persons: Wally Adeyemo, Adeyemo, Antony Blinken, Blinken, ”, ” Blinken, John Kirby, “ It’s, “, we’ve, Saturday’s, CNN’s Jim Sciutto, Max Organizations: CNN, Saturday, Democrats, Administration, National Security Council, White, State Department Locations: United States, Qatar, Iran, Israel, Tehran, Tel Aviv, Qatari

☆ As Covid-testing business drops, Abbott searches for new line of business with consumer wearables
▼ + stars: | 2023-10-10 | by ( Ashley Capoot | ) www.cnbc.com time to read: +3 min

Abbott Laboratories CEO Robert Ford took the stage at the HLTH conference in Las Vegas on Tuesday to discuss the company's expansion into a new market: consumer wearables. For instance, Abbott produces a continuous glucose monitor (CGM) called FreeStyle Libre that patients can use to manage their diabetes. Abbott's most recent model, the FreeStyle Libre 3, can measure glucose levels in real time for up to 14 days. FreeStyle Libre alone generated more than $1.3 billion in sales for Abbott during its second quarter, according to the company's earnings report. "We always believed that we could take this platform that we developed for diabetes and expand it beyond diabetes," Ford said.

Persons: Robert B, Ford, Robert Ford, Abbott, Covid, Margaret Kaczor Andrew, William Blair, CNBC's Erin Black, Lingo Organizations: Abbott, Libre, wearables Locations: Vegas, Las Vegas , Nevada, Las Vegas, U.S

☆ Microsoft announces new AI tools to help doctors deliver better care
▼ + stars: | 2023-10-10 | by ( Ashley Capoot | ) www.cnbc.com time to read: +3 min

Microsoft said the new tools will help eliminate the "time-consuming" process of searching through these sources one by one. He said consolidating disparate data will ultimately help health systems improve care and see more patients. "The current state of technology and Microsoft Fabric and Azure and generative AI, all of that, it's going to change the way we live. And it's probably one of the best shots that we have to solve some of the biggest problems we have within health care," he said. Zoom In Icon Arrows pointing outwards Microsoft's new patient timeline modelNew Azure AI health tools

Persons: Satya Nadella, Stephen Brashear, Arthur Health, Doug King, King Organizations: Getty, Microsoft, Deloitte, Northwestern Medicine, Arthur, CNBC Locations: Bellevue , Washington, Las Vegas, Northwestern

☆ Iran prisoner swap for $6 billion in spotlight after Hamas attacks Israel
▼ + stars: | 2023-10-09 | by ( ) www.reuters.com time to read: +4 min

U.S. Secretary of State Antony Blinken said on Sunday that Iran has not yet been able to spend a single dollar of the $6 billion in funds that were unfrozen in a U.S.-Iran prisoner swap in September. WHAT WAS THE IRAN PRISONER SWAP DEAL? Five U.S. citizens detained by Tehran were allowed to leave the country in exchange for the transfer of $6 billion in Iranian funds that had been frozen in South Korea. The $6 billion was Iranian money that had been frozen in South Korean banks. Under the terms of the Iran prisoner deal, the money can only be used for humanitarian-related purposes, including purchasing food or other goods outside Iran for import, U.S. officials said.

Persons: Amir Cohen, Antony Blinken, Blinken, there’s, Joe Biden, Donald Trump, CNN's, Brian Nelson, we've, Nikki Haley, Heather Timmons, Idrees Ali, Lisa Shumaker Organizations: REUTERS, Rights, Israel, After Washington, State Department, South, Republican, Reuters, Thomson Locations: Gaza, Ashkelon, Israel, Iran, U.S, IRAN, Tehran, South Korea, United States, After, Seoul, Doha, South Carolina

☆ Factbox-Iran Prisoner Swap for $6 Billion in Spotlight After Hamas Attacks Israel
▼ + stars: | 2023-10-09 | by ( Oct. | At A.M. | ) www.usnews.com time to read: +3 min

Persons: Antony Blinken, Blinken, there’s, Joe Biden, Donald Trump, CNN's, Brian Nelson, we've, Nikki Haley, Heather Timmons, Idrees Ali, Lisa Shumaker Organizations: WASHINGTON, Israel, After Washington, State Department, South, Republican, Reuters Locations: Iran, U.S, IRAN, Tehran, South Korea, United States, After, Seoul, Doha, Israel, South Carolina

Search resuls for: "Medical Devices"

25 mentions found